Clinical Trial Update: Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Interleukin-2, Interferon alfa, and Fluorouracil versus observation after surgery for kidney cancer; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• FLUOROURACIL (Fluorouracil)
• Interferon alfa-2b (interferon alfa-2b)
• Interleukin-2 (Aldesleukin) (aldesleukin)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Kidney Cancer | Phase 3 | Status: COMPLETED